메뉴 건너뛰기




Volumn 127, Issue 5, 2013, Pages 624-633

Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: A randomized, controlled trial

Author keywords

Exercise test; prostacyclin analogue; pulmonary arterial hypertension; treprostinil

Indexed keywords

AMBRISENTAN; BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN DERIVATIVE; SILDENAFIL; TADALAFIL; TREPROSTINIL;

EID: 84873566367     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.124388     Document Type: Article
Times cited : (293)

References (36)
  • 2
    • 4644290657 scopus 로고    scopus 로고
    • Treatment of pulmonary arterial hypertension
    • Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351:1425-1436.
    • (2004) N Engl J Med , vol.351 , pp. 1425-1436
    • Humbert, M.1    Sitbon, O.2    Simonneau, G.3
  • 3
    • 0036007307 scopus 로고    scopus 로고
    • Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery
    • Clapp LH, Finney P, Turcato S, Tran S, Rubin LJ, Tinker A. Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. Am J Respir Cell Mol Biol. 2002;26:194-201.
    • (2002) Am J Respir Cell Mol Biol , vol.26 , pp. 194-201
    • Clapp, L.H.1    Finney, P.2    Turcato, S.3    Tran, S.4    Rubin, L.J.5    Tinker, A.6
  • 7
    • 0037086133 scopus 로고    scopus 로고
    • Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A doubleblind, randomized, placebo-controlled trial
    • Treprostinil Study Group
    • Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ; Treprostinil Study Group. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a doubleblind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165:800-804.
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 800-804
    • Simonneau, G.1    Barst, R.J.2    Galie, N.3    Naeije, R.4    Rich, S.5    Bourge, R.C.6    Keogh, A.7    Oudiz, R.8    Frost, A.9    Blackburn, S.D.10    Crow, J.W.11    Rubin, L.J.12
  • 14
    • 33748931278 scopus 로고    scopus 로고
    • Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension
    • Channick RN, Olschewski H, Seeger W, Staub T, Voswinckel R, Rubin LJ. Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. J Am Coll Cardiol. 2006;48: 1433-1437.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 1433-1437
    • Channick, R.N.1    Olschewski, H.2    Seeger, W.3    Staub, T.4    Voswinckel, R.5    Rubin, L.J.6
  • 17
    • 80655137697 scopus 로고    scopus 로고
    • Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension
    • Benza RL, Seeger W, McLaughlin VV, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubin LJ. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant. 2011;30:1327-1333.
    • (2011) J Heart Lung Transplant , vol.30 , pp. 1327-1333
    • Benza, R.L.1    Seeger, W.2    McLaughlin, V.V.3    Channick, R.N.4    Voswinckel, R.5    Tapson, V.F.6    Robbins, I.M.7    Olschewski, H.8    Rubin, L.J.9
  • 18
    • 0036569119 scopus 로고    scopus 로고
    • Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: A randomized, double-blind, placebo-controlled trial
    • Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group
    • Galiè N, Humbert M, Vachiéry JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G; Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2002;39:1496-1502.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 1496-1502
    • Galiè, N.1    Humbert, M.2    Vachiéry, J.L.3    Vizza, C.D.4    Kneussl, M.5    Manes, A.6    Sitbon, O.7    Torbicki, A.8    Delcroix, M.9    Naeije, R.10    Hoeper, M.11    Chaouat, A.12    Morand, S.13    Besse, B.14    Simonneau, G.15
  • 22
    • 84873570634 scopus 로고    scopus 로고
    • Remodulin (treprostinil) injection solution Research Triangle Park, NC: United Therapeutics Corp
    • Remodulin (treprostinil) injection solution [US Food and Drug Administration drug product label]. Research Triangle Park, NC: United Therapeutics Corp; 2011.
    • (2011) US Food and Drug Administration Drug Product Label
  • 25
    • 77953795218 scopus 로고    scopus 로고
    • Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers
    • Gotzkowsky SK, Dingemanse J, Lai A, Mottola D, Laliberte K. Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers. J Clin Pharmacol. 2010;50:829-834.
    • (2010) J Clin Pharmacol , vol.50 , pp. 829-834
    • Gotzkowsky, S.K.1    Dingemanse, J.2    Lai, A.3    Mottola, D.4    Laliberte, K.5
  • 26
    • 84866515810 scopus 로고    scopus 로고
    • Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): A randomized controlled trial
    • Tapson VF, Torres F, Kermeen F, Keogh A, Allen RP, Frantz RP, Badesch DB, Frost AE, Shapiro SM, Laliberte K, Sigman J, Arneson C, Galie N. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. Chest. 2012;142:1383-1390.
    • (2012) Chest , vol.142 , pp. 1383-1390
    • Tapson, V.F.1    Torres, F.2    Kermeen, F.3    Keogh, A.4    Allen, R.P.5    Frantz, R.P.6    Badesch, D.B.7    Frost, A.E.8    Shapiro, S.M.9    Laliberte, K.10    Sigman, J.11    Arneson, C.12    Galie, N.13
  • 28
    • 84872339756 scopus 로고    scopus 로고
    • Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension
    • Published online before print September13 doi:10.1111/1755-5922.12008 Accessed September 1 2012
    • Bourge RC, Tapson VF, Safdar Z, Benza RL, Channick RN, Rosenzweig EB, Shapiro S, White RJ, McSwain CS, Gotzkowsky SK, Nelsen AC, Rubin LJ. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension. Cardiovasc Ther. Published online before print September13, 2012. doi:10.1111/1755-5922.12008. http://onlinelibrary.wiley.com/ doi/10.1111/1755-5922.12008/abstra ct;jsessionid= D66F045CD8BDD338066B5F2A5ECD9A84.d04t01. Accessed September 1, 2012.
    • (2012) Cardiovasc Ther
    • Bourge, R.C.1    Tapson, V.F.2    Safdar, Z.3    Benza, R.L.4    Channick, R.N.5    Rosenzweig, E.B.6    Shapiro, S.7    White, R.J.8    McSwain, C.S.9    Gotzkowsky, S.K.10    Nelsen, A.C.11    Rubin, L.J.12
  • 31
    • 46449124591 scopus 로고    scopus 로고
    • Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) study 1 and 2
    • Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group
    • Galiè N, Olschewski H, Oudiz RJ, Torres F, Frost A, Ghofrani HA, Badesch DB, McGoon MD, McLaughlin VV, Roecker EB, Gerber MJ, Dufton C, Wiens BL, Rubin LJ; Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) study 1 and 2. Circulation. 2008;117:3010-3019.
    • (2008) Circulation , vol.117 , pp. 3010-3019
    • Galiè, N.1    Olschewski, H.2    Oudiz, R.J.3    Torres, F.4    Frost, A.5    Ghofrani, H.A.6    Badesch, D.B.7    McGoon, M.D.8    McLaughlin, V.V.9    Roecker, E.B.10    Gerber, M.J.11    Dufton, C.12    Wiens, B.L.13    Rubin, L.J.14
  • 35
    • 80051559475 scopus 로고    scopus 로고
    • Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study Group. Vardenafil in pulmonary arterial hypertension: A randomized, double-blind, placebo-controlled study
    • Jing ZC, Yu ZX, Shen JY, Wu BX, Xu KF, Zhu XY, Pan L, Zhang ZL, Liu XQ, Zhang YS, Jiang X, Galiè N; Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study Group. Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 2011;183:1723-1729.
    • (2011) Am J Respir Crit Care Med , vol.183 , pp. 1723-1729
    • Jing, Z.C.1    Yu, Z.X.2    Shen, J.Y.3    Wu, B.X.4    Xu, K.F.5    Zhu, X.Y.6    Pan, L.7    Zhang, Z.L.8    Liu, X.Q.9    Zhang, Y.S.10    Jiang, X.11    Galiè, N.12
  • 36
    • 84855163346 scopus 로고    scopus 로고
    • The efficacy and safety of bosentan therapy for Chinese patients with idiopathic pulmonary arterial hypertension: An open-label prospective multicenter study [in Chinese]
    • National Bosentan Therapy for PAH Study Group
    • Dai LZ, Jiang X, Wang Y, Yu ZX, Yao H, Wang GY, Wu BX, Jing ZC; National Bosentan Therapy for PAH Study Group. The efficacy and safety of bosentan therapy for Chinese patients with idiopathic pulmonary arterial hypertension: an open-label, prospective multicenter study [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:124-127.
    • (2011) Zhonghua Xin Xue Guan Bing Za Zhi , vol.39 , pp. 124-127
    • Dai, L.Z.1    Jiang, X.2    Wang, Y.3    Yu, Z.X.4    Yao, H.5    Wang, G.Y.6    Wu, B.X.7    Jing, Z.C.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.